retatrutide news october 2025 A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Demand for Unapproved Weight-Loss Drug

Description

GRADE Study Research Group, Nathan DM, Lachin JM, Bebu I, Burch HB, Buse JB, et al

Can you switch from weight loss injections to pills

Your GLP-1 weight loss journey at Lake Forest Regenesis begins with a medical consultation and health review

Pharmacological GLP-1 RAs replicate these actions, aiding in managing Type 2 diabetes mellitus (T2DM) and promoting weight loss (23)

While those taking semaglutide (Wegovy) and tirzepatide (Mounjaro) lost double the amount of weight compared with people using older jabs 16kg on average patients put on 9.6kg within a year, meaning they could expect to regain all 16kg again in just over 20 months